Catequentinib Hydrochloride (AL3818)

catequentinib hydrochloride · Advenchen Laboratories Nanjing Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Catequentinib Hydrochloride (AL3818), covering 2026-02-27 to 2026-02-27. Get the full timeline:

Most recent: Clinical Trial Update: Catequentinib Hydrochloride (AL3818) Drug-Drug Interaction Study in Healthy Volunteers [Phase 1]